Name of Student: Catherine B.

Jordan Section and Group Number: 3E - Group 2

Name of CI: Sarah Jane M. Rosales, RN MAN Area of Exposure: NEURO Ward

DRUG STUDY – Atorvastatin Calcium

Dosage,
Mechanism of
Name of Drug Frequency, Indication Contraindication Adverse Effects Nursing Responsibilities
Action
Route
Generic Name: Dosage: Inhibits HMG-CoA To reduce risk stroke and  Contraindicated in patients  CNS: insomnia Nursing Considerations:
Atorvastatin 40mg/tab, 1 tab reductase, the enzyme heart attack in type 2 hypersensitive to the drug and in  EENT:  Patient should follow a standard cholesterol-
Calcium that catalyzes the first diabetes patients without those with active liver disease or nasopharyngitis, lowering diet before and during therapy.
Frequency: step in the cholesterol evidence of heart disease unexplained persistent elevations of pharyngolaryngeal  Before treatment, assess patient for underlying
Brand Name: DHS (at synthesis pathway, but with other CV risk transaminase levels. pain causes for hypercholesterolemia and obtain a
Lipitor bedtime) resulting in a decrease factors, and  Use cautiously in patients with  GI: abdominal pain, baseline lipid profile.
in serum cholesterol, revascularization procedures hepatic impairment or heavy diarrhea, dyspepsia,  Watch for signs of myositis and myopathy
Classifications: Route: serum LDLs in patients without evidence alcohol use, in patients with flatulence, nausea (unexplained muscle pain, tenderness, weakness,
Therapeutic Class: PO (associated with of coronary heart disease inadequately treated  GU: UTI malaise, dark urine, fever). Drug may need to be
Antilipemic increased risk of (CHD) but with multiple hypothyroidism, with other drugs  Musculoskeletal: discontinued.
Pharmacologic CAD), and increases risk factors other than associated with myopathy. arthralgia, myalgia, Patient and Family Education:
Class: serum HDLs diabetes, patients with  Withhold or stop drug in patients at extremity pain, muscle  Teach patient about proper dietary
HMG-CoA (associated with CHD, to reduce risks of MI, risk for renal failure caused by spasms, management, weight control, and exercise.
reductase inhibitor decreased risk of hospitalization for CHF, and rhabdomyolysis resulting from musculoskeletal pain Explain their importance in controlling high fat
CAD), increases angina. trauma; in serious, acute conditions  Skin: rash levels.
hepatic LDL recapture that suggest myopathy; and in major  Warn patient to avoid alcohol.
sites, enhances surgery, severe acute infection,  Tell the patient to inform the nurse/physician
reuptake and hypotension, uncontrolled seizures, of all adverse reactions, such as muscle pain,
catabolism of LDL, or severe metabolic, endocrine, or malaise, and fever.
lowers triglyceride electrolyte disorders.  Advise patient that drug can be taken at any
levels. time of day, without regard for meals.

Source: Nursing Drug Source: Nursing Drug Source: Nursing Drug Handbook, Source: Nursing Drug Handbook, 2020 Source: Nursing Drug Handbook, Source: Nursing Drug Handbook, 2020
Handbook, 2020 Handbook, 2020 2020 p. 173 2020 p. 173

1
p. 171 p. 172 p. 171 p. 172